v3.26.1
Statement Of Stockholders Equity - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balance, shares at Dec. 31, 2023   244,783,222    
Balance, amount at Dec. 31, 2023 $ (1,714,226) $ 244,783 $ 74,740,201 $ (76,699,210)
Sale of common stock, net of $11,400 of offering costs, shares   5,300,000    
Sale of common stock, net of $11,400 of offering costs, amount 852,179 $ 5,300 846,879 0
Sale of units for cash, shares   825,000    
Sale of units for cash, amount 66,000 $ 825 65,175 0
Vesting of restricted stock units, shares   1,500,000    
Vesting of restricted stock units, amount 375,000 $ 1,500 373,500 0
Amortization of deferred offering costs (21,051) 0 (21,051) 0
Net Loss (2,001,733) $ 0 0 (2,001,733)
Balance, shares at Dec. 31, 2024   252,408,222    
Balance, amount at Dec. 31, 2024 (2,443,831) $ 252,408 76,004,704 (78,700,943)
Sale of common stock, net of $11,400 of offering costs, shares   800,000    
Sale of common stock, net of $11,400 of offering costs, amount 63,308 $ 800 62,508 0
Vesting of restricted stock units, shares   4,725,000    
Vesting of restricted stock units, amount 1,120,125 $ 4,725 1,115,400 0
Net Loss (2,669,348) $ 0 0 (2,669,348)
Common stock issued for conversion of note payable, shares   757,031    
Common stock issued for conversion of note payable, amount 53,295 $ 757 52,538 0
Balance, shares at Dec. 31, 2025   258,690,253    
Balance, amount at Dec. 31, 2025 $ (3,876,451) $ 258,690 $ 77,235,150 $ (81,370,291)